@OzzieChambers Avatar @OzzieChambers DB

DB posts on X about $tgtx, investment, iv, if you the most. They currently have [---] followers and [--] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [---] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence finance 18.68% stocks 6.59% countries 2.2% financial services 1.1% automotive brands 1.1% cryptocurrencies 1.1% currencies 1.1%

Social topic influence $tgtx #5, investment 3.3%, iv 2.2%, if you 2.2%, $37m 2.2%, btk 2.2%, increase in 2.2%, 30 1.1%, 43 1.1%, #s 1.1%

Top accounts mentioned or mentioned by @zipjet @biotech2050 @semodough @martychargin @fitfounder @ngyojiw @thejobchick @grdecter @dreesenkl @menlobear @newslambert @mbamortgage @nahbhome @nardotrealtor @danbrickner2 @tedstamos @mrjohnnyrainman @dennisc230 @tomsilver39 @thegunnerab

Top assets mentioned TG Therapeutics, Inc. (TGTX) Gilead Sciences, Inc. (GILD) Bitcoin (BTC) BlackRock Inc (BLK) GammaSwap (GS) Novartis AG (NVS)

Top Social Posts

Top posts by engagements in the last [--] hours

"$TGTX Re: the % change for Ocrevus sales [----] vs. [----] I calculate a 4% increase versus the column % change CER showing 9%. Can someone please educate on that Thx"
X Link 2026-01-29T11:15Z [---] followers, [---] engagements

"$TGTX Ocrevus [----] #'s. Some interesting insights on their SC version. I'd say again speaks very well of our upcoming subq version's potential market that will be available in [--] years"
X Link 2026-01-29T10:52Z [---] followers, [----] engagements

"$TGTX And just to refresh a point; the subq trial has an enrollment size of 360"
X Link 2026-02-02T15:07Z [---] followers, [---] engagements

"$TGTX Just a thought. To make an advertising investment at such a hugely visible moment/event like this makes me believe this is another indication that the subq trial is progressing well in conjunction with the growing embracement by MS patients of the #Briumvi IV formulation"
X Link 2026-02-08T22:13Z [---] followers, [----] engagements

"$TGTX The 1st patient on our Azer-cel CAR T now at month [--]. No crap gap doing well. 👍👍"
X Link 2026-01-20T16:39Z [---] followers, [----] engagements

"$TGTX Those that follow closely MW's thoughts on market space for injections vs. infusion his WAG of 33% for injections; I just saw a discussion on this topic in an Ocrevus group and amazingly 66% preferred the infusions over their Zunovo having done both. Fascinating.fwiw"
X Link 2026-01-20T12:26Z [---] followers, [----] engagements

"$TGTX By Q2's CC the subq trial based on the 1st [--] months enrollment rate will be fully enrolled. You'll have patients that have received either [--] doses or [--] doses. (every other month or every 3rd month). I'd think BP is/will be closely monitoring these next [--] months. 👍jmo"
X Link 2026-02-02T14:33Z [---] followers, [----] engagements

"$TGTX Still have reporting for tutes until 2/16 for Q4. So far looking solid near an oth at 86.3%. Vanguard +319K shares; GS +531K; BNP Paribas +612K; and Congress +1.9M"
X Link 2026-02-11T00:16Z [---] followers, [---] engagements

"@thejobchick Perhaps too many are living beyond their means A novel idea called budgeting. 🤔🤔"
X Link 2026-02-14T18:15Z [---] followers, [---] engagements

"$GILD #Remdesivir The demand continues. https://www.yahoo.com/news/m/ac7be98f-f4e1-3f5c-b04a-6f5403971c68/use-of-experimental-covid-19.html https://www.yahoo.com/news/m/ac7be98f-f4e1-3f5c-b04a-6f5403971c68/use-of-experimental-covid-19.html"
X Link 2020-03-27T13:58Z [---] followers, [--] engagements

"$JRV $JRV.V $JRVMF FORD SAYS PASSENGER VEHICLES IN EUROPE WILL BE ALL-ELECTRIC OR PLUG-IN HYBRID BY MID-2026; MOVING TO ALL-ELECTRIC BY [----] $F"
X Link 2021-02-17T11:01Z [---] followers, [--] engagements

"@GRDecter Those 40M probably invested in Bitcoin those [--] years of -0- payments made 100's of K's and now are debt free; cashflow +.they are college educated right 😉"
X Link 2023-06-20T18:38Z [---] followers, [---] engagements

"@Dreesenkl $TGTX I am quietly monitoring numerous #MS groups on the internet & #Briumvi is in a quiet explosive growth mode as the word continues to spread being on the market just [--] months. A great start/great feedback from patients. Both new and patients switching from #Ocrevus. 👍"
X Link 2023-09-27T11:30Z [---] followers, [----] engagements

"@menlobear Fed rate was 20% in early 80's. We survived. Get over it"
X Link 2023-09-27T21:31Z [---] followers, [---] engagements

"$TGTX If you ever want a great example of the dark side of Wall Street this is it. #Briumvi perhaps the best MS drug recently introduced is threatening the market share of #Oscrevus. PPS getting walloped by large forces 😉but that'll change as it takes more of the market"
X Link 2023-10-06T14:00Z [---] followers, [----] engagements

"@NewsLambert @MBAMortgage @NAHBhome @nardotrealtor Well hopefully Powell laughs and throws the letter in the can. Econ [---] inflation hurts more people than higher rates"
X Link 2023-10-09T18:04Z [---] followers, [---] engagements

"@FitFounder Yes the game isn't won on game day; it's on the practice field"
X Link 2023-10-12T16:50Z [---] followers, [--] engagements

"$TGTX It's happening. Best week yet and just beginning"
X Link 2023-10-20T10:21Z [---] followers, [----] engagements

"@Biotech2050 @DanBrickner2 And from the CC "Over the course of the year we have continued to invest in Briumvi inventory with approximately $34 million now on our balance sheet of which $24 million is reflected in the current quarter cash burn.""
X Link 2023-11-07T11:03Z [---] followers, [--] engagements

"$TGTX I unknowingly (initially) posted a teaser from SA of TGTX's Q3 earnings CC the other day. For those interested here it is in its entirety"
X Link 2023-11-07T21:42Z [---] followers, [---] engagements

"$TGTX #Briumvi You be the judge where we are going. Trx total for Q3 [--]. Trx to date Q4; with [--] weeks down and [--] weeks left [--]. 👍👍🤣"
X Link 2023-11-17T10:33Z [---] followers, [----] engagements

"$TGTX update. Symphony Trx total [--] Q3-63. Trx Q4 [--] date w/7 weeks down & [--] weeks left [--]. Using Symphony #'s only [--] a gauge [--] hit MW's top guidance of $37M they need a Trx of [--]. Those [--] weeks a holiday period & [--] holiday weeks within that. Still believe they nail it"
X Link 2023-11-24T11:55Z [---] followers, [----] engagements

"@TedStamos @zipjet Exactly Not a requirement but an added bonus"
X Link 2023-12-05T16:03Z [---] followers, [--] engagements

"$TGTX So you have one BTK MS drug put on hold a few days ago then another BTK drug fail today Wouldn't be surprised to see TGTX jump as the word spreads. #Briumvi"
X Link 2023-12-06T00:32Z [---] followers, [---] engagements

"$TGTX Is the BTK news the catalyst to push this to close the gap to [--] Stay tuned. Guess we'll see. 👍"
X Link 2023-12-06T00:46Z [---] followers, [----] engagements

"$TGTX update. Symphony Trx total [--] Q3-63. Trx Q4 [--] date w/9 wks dwn & [--] wks left [--] min (perhaps a few more [--] Tday wk). Using Symphony #'s only [--] a gauge [--] hit MW's top guidance of $37M they need a Trx of [--]. The [--] weeks left a holiday "period" of which [--] are holiday wks. 👍"
X Link 2023-12-08T09:54Z [---] followers, [----] engagements

"@MrJohnnyRainman Envious"
X Link 2023-12-08T11:38Z [---] followers, [--] engagements

"$TGTX Continues to follow the script of late 2019/early [----]. Something I've observed over the many years being in the markets; how technicals and fundamentals align. The chicken or the egg. Looking forward to [----] as it develops 👍👍👍 $TGTX Speaking strictly LT (monthly) technicals; the last time this was in this position was the Nov Dec time period [----]. U can see what happened in the nxt [--] months after that. Interesting how that may coincidentally align w/#Briumvi script growth. A great [--] weeks & day 👍👍 $TGTX Speaking strictly LT (monthly) technicals; the last time this was in this"
X Link 2024-01-06T12:56Z [--] followers, [----] engagements

"$TGTX Blackrock +1.6M shares in Q4. https://t.co/KQ7VL8vCPM https://t.co/KQ7VL8vCPM"
X Link 2024-01-27T16:33Z [---] followers, [----] engagements

"@FitFounder Better understanding how important diet plays in weight loss"
X Link 2024-03-10T23:49Z [---] followers, [--] engagements

"$TGTX For those interested in reading the Q4 CC transcript. I always find a few tidbits that I may have missed when listening to them. Exciting times for the company. 👍 https://www.insidermonkey.com/blog/tg-therapeutics-inc-nasdaqtgtx-q1-2024-earnings-call-transcript-1296294/ https://www.insidermonkey.com/blog/tg-therapeutics-inc-nasdaqtgtx-q1-2024-earnings-call-transcript-1296294/"
X Link 2024-05-04T16:37Z [---] followers, [---] engagements

"@dennisc230 $TGTX it is a buyout candidate. :)"
X Link 2024-05-14T00:41Z [---] followers, [---] engagements

"While $GS ignored $TGTX in the earnings report they have just increased their position 62% in Q2 adding 800K shares. Let the $$$ do the talking. @TomSilver39 No idea why GS covers $TGTX - they mention about [--] other biotechs that had earnings last week but not one mention of $TGTX @TomSilver39 No idea why GS covers $TGTX - they mention about [--] other biotechs that had earnings last week but not one mention of $TGTX"
X Link 2024-08-14T08:01Z [---] followers, [----] engagements

"@semodough @zipjet B of A's position was established in Q1. They actually sold 120K shares Q2 fwiw. Regardless still amusing that they see the $ and light. 😉"
X Link 2024-08-15T12:34Z [---] followers, [---] engagements

"$TGTX To lay this to rest.1 of [--]. And I quote MW from Q2 [----] CC "We treated our first MS patients with subcutaneous BRIUMVI in a newly launched Phase [--] study to assess bioequivalence of subcu versus IV BRIUMVI." con't"
X Link 2024-08-20T11:35Z [---] followers, [---] engagements

"@zipjet @thegunnerab $TGTX Unless they have a good feel know where their investment is headed.😉"
X Link 2024-10-08T09:45Z [---] followers, [---] engagements

"$TGTX So between Q2 and Q3 #Blackrock have added [--------] shares. 👍👏🤑"
X Link 2024-10-08T11:34Z [---] followers, [---] engagements

"@gwizmatty @Biotech2050 @BioStocks @Merck No BP will be able to acquire $TGTX for only a 50% premium"
X Link 2024-10-29T10:55Z [---] followers, [---] engagements

"$TGTX Q3 CC 11/4"
X Link 2024-11-01T12:07Z [---] followers, [---] engagements

"$TGTX Tute holdings now 70.22%. Long time since we had been above 70%. 👍👊"
X Link 2024-11-03T19:55Z [---] followers, [---] engagements

"$TGTX Great quarter and year to date And the way they are investing in their future in various ways highlighted in the CC; no doubt they are going to be a giant in the MS field 👍"
X Link 2024-11-04T14:24Z [---] followers, [---] engagements

"$TGTX Quick calcs using 20% growth for Q's [---] and 10% Q3 for [----] and 2026; [----] $600M and [----] just over $1B. I'd say these #'s again ballpark and perhaps somewhat conservative. And this is without the VA and Europe sales. This is going to get crazy going forward"
X Link 2024-11-05T02:52Z [---] followers, [----] engagements

"$TGTX [--]. With all those analysts on the Q3 CC you have [--] wonder why none of them asked any questions re: the two biggest elephants in the room: where is the income from the VA contract & the Neuraxpharm agreement. We know [--] a fact in both cases #Briumvi is being dispensed con't"
X Link 2024-11-10T10:00Z [---] followers, [---] engagements

"$TGTX [--]. Regardless of the income amount why weren't there any questions Were they told quietly in advance not to ask regarding those two topics 🤔"
X Link 2024-11-10T10:02Z [---] followers, [---] engagements

"@Biotech2050 $TGTX Then maybe the [----] # of $325M in sales possible some are saying. I am more of the school in the range of $310-315M. Either way a win win 👍"
X Link 2024-11-10T10:23Z [---] followers, [---] engagements

"$TGTX Let's not forgot in October to start Q4 they had their largest enrollment ever in the hub 👍👍"
X Link 2024-11-11T17:39Z [---] followers, [----] engagements

"$TGTX Great honor and just one more reason if/when a BO happens it won't be less than triple digits. TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the [----] Deloitte Technology Fast [---] $TGTX https://t.co/auceSdnx76 TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the [----] Deloitte Technology Fast [---] $TGTX https://t.co/auceSdnx76"
X Link 2024-11-21T11:09Z [---] followers, [----] engagements

"$TGTX So here we are. I believe these next x months are going to get very interesting 👍 $TGTX Speaking strictly LT (monthly) technicals; the last time this was in this position was the Nov Dec time period [----]. U can see what happened in the nxt [--] months after that. Interesting how that may coincidentally align w/#Briumvi script growth. A great [--] weeks & day 👍👍 $TGTX Speaking strictly LT (monthly) technicals; the last time this was in this position was the Nov Dec time period [----]. U can see what happened in the nxt [--] months after that. Interesting how that may coincidentally align"
X Link 2024-11-23T10:55Z [---] followers, [---] engagements

"$TGTX The short % is frequently cited for the stock. Just keep in mind any that established that position in the last [--] months is now under water. 🙃👍"
X Link 2024-11-23T11:36Z [---] followers, [---] engagements

"@MartyChargin It will get better"
X Link 2024-11-23T16:38Z [---] followers, [---] engagements

"@semodough $TGTX I'll stick with my WAG's that they have a shot at $700M in [----] and $1B in [----]. Subq imo best case no impact until [----]. More interested when they will begin adding in Euro and VA revenues. 👍"
X Link 2024-11-24T19:59Z [---] followers, [---] engagements

"$TGTX JP Morgan raises PT from $30 to $43. They're learning getting there. 👍"
X Link 2024-11-25T11:11Z [---] followers, [----] engagements

"$TGTX Just a theory. I think there as an unspoken fear among shorts that many don't want to cover here; afraid that will break the dam wide open; hoping it will come down a little to lower losses. BUT once they do start covering and new investors buy in; look out 👍"
X Link 2024-11-25T12:22Z [---] followers, [---] engagements

"@YadiGoat @PCM_bio $TGTX has already been profitable for last [--] quarters"
X Link 2024-11-25T23:49Z [---] followers, [---] engagements

"$TGTX May be a good consolidation area after the recent run creating a handle for a C&H. A conservative PT from the recent "cup" formed in the past [--] weeks [--]. We'd take it 👍"
X Link 2024-11-26T10:08Z [---] followers, [----] engagements

"$TGTX #Briumvi Italian Medicines Agency AIFA approved the reimbursement of Briumvi. Comunicato_AIFA_25-2024_EN.pdf"
X Link 2024-11-28T13:58Z [---] followers, [----] engagements

"$TGTX Perhaps he'll give insight on how scripts were advancing in November and any other updates"
X Link 2024-11-29T13:07Z [---] followers, [---] engagements

"$TGTX Believe this handle could take a # of days to develop now that unless there is unexpected news many will be waiting for the JPM in January. $TGTX May be a good consolidation area after the recent run creating a handle for a C&H. A conservative PT from the recent "cup" formed in the past [--] weeks [--]. We'd take it 👍 $TGTX May be a good consolidation area after the recent run creating a handle for a C&H. A conservative PT from the recent "cup" formed in the past [--] weeks [--]. We'd take it 👍"
X Link 2024-12-03T16:29Z [---] followers, [---] engagements

"@MANGo9215 @elerianm Exactly The economy is humming No rate cut is necessary"
X Link 2024-12-06T14:11Z [---] followers, [--] engagements

"$TGTX To achieve this at the beginning of the year when insurance deductibles are resetting is very huge; speaks volumes where the company is heading with the quality #1 CD20 drug #Briumvi; and now sits with institutional investment of 85%. January and Feb highest in $tgtx hub for new patients since launch. 🚀 January and Feb highest in $tgtx hub for new patients since launch. 🚀"
X Link 2025-03-04T10:16Z [---] followers, [----] engagements

"$TGTX Nice article overview on the company. Not sure if it was posted before. https://stkt.co/e8dXqGQV https://stkt.co/e8dXqGQV"
X Link 2025-03-21T10:15Z [---] followers, [---] engagements

"$TGTX Great to see MW always thinking ahead. http://www.fujifilm.com/us/en/news/biotechnology/fujifilm-diosynth-biotechnologies-signs-manufacturing-supply-agreement-with-tg-therapeutics http://www.fujifilm.com/us/en/news/biotechnology/fujifilm-diosynth-biotechnologies-signs-manufacturing-supply-agreement-with-tg-therapeutics"
X Link 2025-04-03T10:27Z [---] followers, [----] engagements

"$TGTX With Kesimpta reporting a 43% growth from previous quarter; I'm feeling pretty good of my $125-135M # for #Briumvi for Q1. 👍"
X Link 2025-04-29T10:22Z [---] followers, [----] engagements

"$TGTX #Briumvi The annual cost in Germany $51000. In the U.S. the annual cost $59000. About 13% less"
X Link 2025-05-12T08:35Z [---] followers, [--] engagements

"$TGTX A hard question [--] answer that no [--] wanted [--] address & makes U think. I don't know the answer; why I asked. It is a very frothy PE. Earnings will b increasing but clinical trial expenses will also soon be increasing. I believe we R fortunate [--] B up 125% in [--] year. Patience @semodough I'm a LT investor and the PE is currently [---]. What do you think is a fair PPS I recognize profitability will be ramping in the next few years. @semodough I'm a LT investor and the PE is currently [---]. What do you think is a fair PPS I recognize profitability will be ramping in the next few years"
X Link 2025-06-12T13:25Z [---] followers, [---] engagements

"$TGTX #Briumvi knocking on 2-1/2 years on the market. Q1 typical weakness in drug sales and it showed with a 15-16% sales growth from Q4. This 1/4 ending in a couple weeks imo very important to the show me Mr. Market.🤞"
X Link 2025-06-13T09:25Z [---] followers, [---] engagements

"$TGTX [--] week left for Q2 sales. As we know Q1 is habitually challenged in bio sales (was +15% over Q4). That said imo Q2 sales need to show 25-35% increase over Q1 to justify current pps or greater. Again jmo"
X Link 2025-06-23T12:05Z [---] followers, [---] engagements

"@PoliMacchiato @MartyChargin You're correct but you said nothing about technicals. Instead you're talking about the drug and sales being poor. No problem"
X Link 2025-06-30T15:15Z [---] followers, [--] engagements

"$TGTX Briumvi ads reported on Hulu Paramount+ and TBS this past weekend. 🙌👍"
X Link 2025-08-11T12:28Z [---] followers, [---] engagements

"$TGTX continues its march. $TGTX With Briumvi sales projected to cross $1B by [----] @TGTherapeutics may be Wall Streets next biotech superstar. Heres the full story. https://t.co/KwYkGFNpCv $TGTX With Briumvi sales projected to cross $1B by [----] @TGTherapeutics may be Wall Streets next biotech superstar. Heres the full story. https://t.co/KwYkGFNpCv"
X Link 2025-09-03T17:45Z [---] followers, [---] engagements

"$TGTX Firing on all cylinders. CAR-T azer-cel [--] of the [--] sites are now recruiting. NCT06680037 A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders http://ClinicalTrials.gov http://ClinicalTrials.gov"
X Link 2025-09-24T15:20Z [---] followers, [----] engagements

"$TGTX Excellent detailed article on the topic Azer-cel their allogeneic Car-T therapy drug in PI and their 1st patient. https://www.bioxconomy.com/modalities/multiple-sclerosis-patient-treated-with-allogeneic-car-t-therapyfbclid=IwY2xjawNCFjFleHRuA2FlbQIxMABicmlkETFYdjgzUDU0ZHh4Q0Yxc3B4AR6eAhYaHWCmwa-KQnq3c_kIykF_lB_v2p1lD7i7t86dBUlm12pdt_YJHWK3jQ_aem_5ol1avhkggFvnwWUu13AIA"
X Link 2025-09-25T12:56Z [---] followers, 17.3K engagements

"$TGTX They just keep quietly executing. This the subq trial the Car T trial and increasing sales of #Briumvi. All for a very conservative pps"
X Link 2025-10-28T11:57Z [---] followers, [---] engagements

"@BioWreck2022 @Sandeman52 Months ago I tweeted per company; "We believe we'll be in a position to share data from this study early next year and we are still targeting starting a pivotal trial for subcutaneous BRIUMVI by mid-2025." Based on that [----] [----] time period"
X Link 2025-02-13T11:51Z [---] followers, [--] engagements

"$TGTX Great to see MW was ahead of the tariff game. https://fujifilmbiotechnologies.fujifilm.com/about/news/fujifilm-diosynth-biotechnologies-signs-manufacturing-supply-agreement-with-tg-therapeutics/ https://fujifilmbiotechnologies.fujifilm.com/about/news/fujifilm-diosynth-biotechnologies-signs-manufacturing-supply-agreement-with-tg-therapeutics/"
X Link 2025-09-26T07:28Z [---] followers, [---] engagements

"@ngyojiw $183M 14% over Q3. Don't believe that will be an issue based on the facts I presented"
X Link 2025-11-03T12:48Z [---] followers, [--] engagements

"@MartyChargin @Lucy3370 I'll stick with what I said is possible"
X Link 2025-11-03T12:51Z [---] followers, [--] engagements

"@marketplunger1 #TG Therapeutics $TGTX Will become the #1 CD20 MS drug offering both the current IV administration & by early [----] the only true subq administration of the drug. PK data on PIII data less than [--] months away"
X Link 2025-12-06T13:35Z [---] followers, [----] engagements

"@unusual_whales $TGTX"
X Link 2026-01-10T23:11Z [---] followers, [---] engagements

"@ngyojiw @TimCarmichael3 As stated it is an allogeneic CAR-T cell therapy targeted at PPMS patients. $TGTX"
X Link 2026-01-24T18:22Z [---] followers, [---] engagements

"$TGTX Novartis reported a 44% cc jump in Kesimpta sales to $1.22B in Q3 driven by strong demand across regions. Great news for our upcoming Q3 CC & subq version 👍And not so well for #Ocrevus. 👎"
X Link 2025-10-28T09:40Z [---] followers, [---] engagements

"$TGTX A little food [--] thought. Kesimpta's rate of growth from 2nd to 3rd year of launch Q3-Q3 was 68% ($242M- $373M). Within a week we'll know Briumvi's. Q3 [--] 2nd year was $83.3M. Chances r good $TGTX will push 90-100%. Also shows the power of subq (& cost 😉). For TG soon 👍"
X Link 2025-10-29T10:01Z [---] followers, [----] engagements

"$TGTX I don't believe knowledgeable long-term investors are concerned about the price action today. Disappointed yes. "If you aren't willing to own a stock for [--] years don't even think about owning it for [--] minutes." . Warren Buffet"
X Link 2025-11-03T18:55Z [---] followers, [---] engagements

"$TGTX More positives [--] their CAR T drug Azer-cel [--] PPMS Patient #1 just passed the 6-month mark w/ extensive testing being done. The level of improvement being seen is not typically witnessed w/ standard DMTs. Patient's EDSS score has gone from [--] on day [--] to now a score of 4"
X Link 2025-12-12T11:58Z [---] followers, [----] engagements

"$TGTX Trial recruitment 50% completed in [--] months for #Briumvi Subq Says a great deal about the excitement and demand for this version of the future #1 CD20 MS drug #Briumvi Still hoping to see a push for accelerated approval. 👍🤞 $TGTX #JPM26 CEO most excited about SUBq phase [--] over 50% enrolled data year end - so much potential upside - major advantages over others - $TGTX - one of lowest cost structure in #BIOTECHS with this Revenue $TGTX #JPM26 CEO most excited about SUBq phase [--] over 50% enrolled data year end - so much potential upside - major advantages over others - $TGTX - one of"
X Link 2026-01-14T11:33Z [---] followers, [---] engagements

"$TGTX 🤑 $TGTX Jefferies BUY PT $46 plans to release topline data for D1 and D15 combined dosing Briumvi in mid'26 and topline data for SC Briumvi by YE26/ 1Q27 believe will be a major stock moving event with strategic value given potential best-in-class profile. Bottom line. Briumvi $TGTX Jefferies BUY PT $46 plans to release topline data for D1 and D15 combined dosing Briumvi in mid'26 and topline data for SC Briumvi by YE26/ 1Q27 believe will be a major stock moving event with strategic value given potential best-in-class profile. Bottom line. Briumvi"
X Link 2026-01-14T13:05Z [---] followers, [---] engagements

"$TGTX For those not familiar with EDSS scoring in MS take a look at the scale at Wikipedia.Expanded Disability Status Scale and see how big of an improvement it is to go from a [--] to a [--]. Sorry being challenged at the moment to post the link. 🙃"
X Link 2025-12-12T12:20Z [---] followers, [---] engagements

"$TGTX I still believe they have a shot of a 100% increase in rev in [----] (pushing $620M) from [----] as the European growth rate is in its infancy will be great enough to push it there in addition to the increase in advertising; and increase in repeating patients. 👍👊"
X Link 2025-11-03T12:21Z [---] followers, [---] engagements

"$TGTX Keep on executing. Only need [--] 34👍 or so patients to fill the trial. $DTIL $TGTX TG-Azercel-101 study in autoimmune disease has now added two more US sites bringign the total to [--]. Ohio State and University of Michigan. LFG https://t.co/uU9T2mLnT4 https://t.co/jX5aGKCTik $DTIL $TGTX TG-Azercel-101 study in autoimmune disease has now added two more US sites bringign the total to [--]. Ohio State and University of Michigan. LFG https://t.co/uU9T2mLnT4 https://t.co/jX5aGKCTik"
X Link 2025-11-03T15:19Z [---] followers, [---] engagements

"$TGTX HC Wainwright bumps PT to $60"
X Link 2025-10-06T11:04Z [---] followers, [---] engagements

"$TGTX My calcs tell me they have a very good shot at 100% increase in revenue ($600M+) vs. [----] using 15% rev increase in both Q3 and Q4"
X Link 2025-10-24T14:59Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing